El Trastorno de deseo sexual hipoactivo femenino (TDSH) es un diagnóstico médico que describe una situación en la que disminuye el deseo sexual de la mujer de forma persistente durante 6 meses o más, con ausencia de fantasías sexuales y escaso o nulo interés por la actividad sexual. El cuadro puede asociarse a ansiedad, angustia y dificultad con las relaciones interpersonales.

Leer el artículo completo en Wikipedia · CC-BY-SA

Female sexual arousal disorder (FSAD) is a disorder characterized by a persistent or recurrent inability to attain sexual arousal or to maintain arousal until the completion of a sexual activity. The diagnosis can also refer to an inadequate lubrication-swelling response normally present during arousal and sexual activity. The condition should be distinguished from a general loss of interest in sexual activity and from other sexual dysfunctions, such as the orgasmic disorder (anorgasmia) and hypoactive sexual desire disorder, which is characterized as a lack or absence of sexual fantasies and desire for sexual activity for some period of time. Although female sexual dysfunction is currently a contested diagnostic, it has become more common in recent years to use testosterone off-label -based drugs to treat FSAD. While drug companies are technically not allowed to market these drugs for off-label uses, sharing the information with doctors at CME conferences has proved to be an effective way to navigate around the FDA approval process.

Leer el artículo completo en Wikipedia · CC-BY-SA